A post-marketing database surveillance to investigate the risk of diagnosed lactic acidosis events in MRSA patients treated with tedizolid or linezolid in Japan (MK-1986-046)

14/01/2026
14/01/2026
EU PAS number:
EUPAS1000000894
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

MK-1986-046_post-marketing database study_Lactic acidosis_protocol_final-redactiond.pdf

English (1.66 MB - PDF) View document
Study results
Study report
Other information